Despite the evidence suggesting a link between genetically proxied ACE inhibition and colorectal cancer, however, these findings cannot demonstrate a causal relationship between ACE inhibitor use and colorectal cancer risk; only a randomized controlled trial could establish this relationship. The gene discussed is ACE; the disease is colorectal cancer.